MedDataX Logo

Impact of Arterial Cannulation Site on Vasopressor Requirement in Cardiac Surgery

NCT ID: NCT04620694

Last Updated: 2020-11-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

350 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-10-01

Study Completion Date

2021-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Choice of arterial cannulation site during cardiac surgery is controversial. Some physicians in our institution prefer radial artery site, others prefer aortic site (via femoral artery or brachial artery). The investigators aim to compare these two strategies for vasopressor requirement. The study hypothesis is that radial artery cannulation is associated with a larger dose of vasopressor due aortic to radial arterial pressure gradient phenomenon.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cardiac Disease

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Cardiac surgery Aortic to radial arterial pressure gradient Vasopressor

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Radial artery cannulation

Patients whom radial artery was cannulated at the beginning of the surgery.

No interventions assigned to this group

Aortic cannulation (brachial or femoral artery)

Patients whom femoral or brachial artery was cannulated at the beginning of the surgery.

Active comparator

Choice of arterial cannulation site at the beginning of the surgery

Intervention Type DEVICE

Choice of arterial cannulation site at the beginning of the surgery is at the discretion of the anesthesia physician.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Choice of arterial cannulation site at the beginning of the surgery

Choice of arterial cannulation site at the beginning of the surgery is at the discretion of the anesthesia physician.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult patient
* Scheduled for cardiac surgery with cardiopulmonary bypass

Exclusion Criteria

* More than one arterial cannula at the beginning of the surgery
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hospices Civils de Lyon

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hôpital Louis Pradel

Lyon, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Remi Schweizer, MD

Role: CONTACT

Phone: 0033472318933

Email: [email protected]

Jean Luc FELLAHI, MD

Role: CONTACT

Phone: 0033472318933

Email: [email protected]

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

69HCL20_0947

Identifier Type: -

Identifier Source: org_study_id